Therapy Monitoring with Fluorine-18 FDG-PET and Fluorine-18 FDG-PET/CT

被引：0

作者：

Wieder, Hinrich A. ^{[1
]}

Herrmann, Ken ^{[2
]}

机构：

[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-81675 Munich, Germany

[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany

来源：

PET CLINICS | 2008年 / 3卷 / 02期

关键词：

FDG; PET-CT; Gastrointestinal cancer; Therapy monitoring;

D O I：

10.1016/j.cpet.2008.08.009

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

PET with the glucose analog [18F]-FDG is increasingly used to monitor tumor response in patients undergoing chemotherapy and chemoradiotherapy. The clinical value of FDG PET for differentiation of residual tumor and therapy-induced fibrosis has been documented for gastrointestinal cancer. Furthermore, quantitative assessment of therapy-induced changes in tumor [18F]-FDG uptake may allow the prediction of tumor response and patient outcome very early in the course of therapy. This suggests that FDG PET may be used to identify nonresponders early during neoadjuvant chemoradiotherapy, allowing for early modifications of the treatment protocol.

引用

页码：217 / +

页数：11

共 50 条

[1] Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer - Taiwanese experiences
Lin, WY
Tsai, SC
Cheng, KY
Yen, RF
Kao, CH
[J]. CANCER INVESTIGATION, 2002, 20 (5-6) : 725 - 729
[2] Fluorine-18 FDG-PET for the detection of recurrent and/or metastatic 131-iodine negative thyroid carcinoma
Flores, JA
Becherer, A
Kaserer, K
Cerny, C
Nowotny, C
Pötzi, C
Niederle, B
Dudczak, R
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1093 - 1093
[3] PET imaging of musculoskeletal tumours with fluorine-18 α-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET
Hideomi Watanabe
Tomio Inoue
Tetsuya Shinozaki
Takashi Yanagawa
Adel Refaat Ahmed
Katsumi Tomiyoshi
Noboru Oriuchi
Mari Tokunaga
Jun Aoki
Keigo Endo
Kenji Takagishi
[J]. European Journal of Nuclear Medicine, 2000, 27 : 1509 - 1517
[4] Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis
Matteo Bassetti
Maria Merelli
Fernando Di Gregorio
Paola Della Siega
Maria Screm
Claudio Scarparo
Elda Righi
[J]. Skeletal Radiology, 2017, 46 : 777 - 783
[5] Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis
Bassetti, Matteo
Merelli, Maria
Di Gregorio, Fernando
Della Siega, Paola
Screm, Maria
Scarparo, Claudio
Righi, Elda
[J]. SKELETAL RADIOLOGY, 2017, 46 (06) : 777 - 783
[6] PET imaging of musculoskeletal tumours with fluorine-18 α-methyltyrosine:: comparison with fluorine-18 fluorodeoxyglucose PET
Watanabe, H
Inoue, T
Shinozaki, T
Yanagawa, T
Ahmed, AR
Tomiyoshi, K
Oriuchi, N
Tokunaga, M
Aoki, J
Endo, K
Takagishi, K
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (10) : 1509 - 1517
[7] Fluorine-18 FDG PET/CT has a role in the Predicting the Outcome of Hepatocellular Carcinoma
Pan, L.
Gu, P.
Huang, G.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S263 - S263
[8] Production of fluorine-18 FDG in Brazil
不详
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (01): : 95 - 95
[9] Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET
Keishi Horiguchi
Masahiko Tosaka
Tetsuya Higuchi
Yukiko Arisaka
Kenichi Sugawara
Junko Hirato
Hideaki Yokoo
Yoshito Tsushima
Yuhei Yoshimoto
[J]. EJNMMI Research, 7
[10] Preliminary evaluation of fluorine-18 alpha-methyl tyrosine PET in the differential diagnosis of pancreatic tumor; comparative study with FDG-PET
Higuchi, T.
Oriuchi, N.
Miyakubo, M.
Ishikita, T.
Otake, H.
Koyama, K.
Endo, K.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S257 - S257

← 1 2 3 4 5 →